{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:19:09Z","timestamp":1761293949311,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Oncology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.oraloncology.2019.06.024","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T10:28:53Z","timestamp":1561544933000},"page":"104343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Medication related osteonecrosis of jaw in a leukemia patient undergoing systemic arsenic trioxide therapy: A rare case report"],"prefix":"10.1016","volume":"99","author":[{"given":"Mathangi","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1907-9858","authenticated-orcid":false,"given":"Ravindranath","family":"Vineetha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adarsh","family":"Kudva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oraloncology.2019.06.024_b0005","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1182\/blood-2007-07-102798","article-title":"Acute promyelocytic leukemia: from highly fatal to highly curable","volume":"111","author":"Wang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.oraloncology.2019.06.024_b0010","unstructured":"Nematollahi S, Acharya UH, Krishnadasan R. ATRA-associated bone marrow necrosis in a patient with acute promyelocytic leukemia a case presentation and review of the literature n.d.;11:23\u20138."},{"key":"10.1016\/j.oraloncology.2019.06.024_b0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11864-012-0223-3","article-title":"Role of arsenic trioxide in acute promyelocytic leukemia","volume":"14","author":"Iland","year":"2013","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.oraloncology.2019.06.024_b0020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1300874","article-title":"Retinoic acid and arsenic trioxide for acute promyelocytic leukemia","volume":"369","author":"Lo-Coco","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oraloncology.2019.06.024_b0025","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1182\/blood-2011-10-388496","article-title":"The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML\/RARA through inhibition of PML body recycling","volume":"120","author":"L\u00e5ng","year":"2012","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.oraloncology.2019.06.024_b0030","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/cncr.11314","article-title":"Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: The M. D. Anderson experience","volume":"97","author":"Lazo","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.oraloncology.2019.06.024_b0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.oooo.2018.09.008","article-title":"Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment","volume":"127","author":"Nicolatou-Galitis","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.oraloncology.2019.06.024_b0040","first-page":"679","article-title":"Treatment: report of a case","volume":"3","author":"Worthington","year":"1996","journal-title":"Text"},{"key":"10.1016\/j.oraloncology.2019.06.024_b0045","first-page":"1","article-title":"Mandibular bone and soft tissues necrosis caused by an arsenical endodontic preparation treated with piezoelectric device","volume":"2013","author":"Giudice","year":"2013","journal-title":"Case Rep Dent"},{"key":"10.1016\/j.oraloncology.2019.06.024_b0050","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jfma.2012.07.023","article-title":"Gingival and localized alveolar bone necrosisrelated to the use of arsenic trioxidepaste-Two case reports","volume":"113","author":"Chen","year":"2014","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.oraloncology.2019.06.024_b0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.oraloncology.2018.08.003","article-title":"Risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: A systematic review with meta-analyses","volume":"85","author":"Karna","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oraloncology.2019.06.024_b0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.oraloncology.2018.08.003","article-title":"Risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: A systematic review with meta-analyses","volume":"85","author":"Karna","year":"2018","journal-title":"Oral Oncol [Internet]"}],"container-title":["Oral Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368837519302131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368837519302131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:09:36Z","timestamp":1761282576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368837519302131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":12,"alternative-id":["S1368837519302131"],"URL":"https:\/\/doi.org\/10.1016\/j.oraloncology.2019.06.024","relation":{},"ISSN":["1368-8375"],"issn-type":[{"type":"print","value":"1368-8375"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication related osteonecrosis of jaw in a leukemia patient undergoing systemic arsenic trioxide therapy: A rare case report","name":"articletitle","label":"Article Title"},{"value":"Oral Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oraloncology.2019.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104343"}}